VR Adviser »

Perceptive Cap Solutions Cor Cl A shares owned by VR Adviser

Quarter-by-quarter ownership of Perceptive Cap Solutions Cor Cl A shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Perceptive Cap Solutions Cor Cl A

Tip: Access up to 7 years of quarterly data

All positions including Perceptive Cap Solutions Cor Cl A held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perceptive Cap Solutions Cor Cl A by VR Adviser

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.5M 750k 10.06

More positions owned by VR Adviser

Apogee Therapeutics (APGE)
Enliven Therapeutics (ELVN)
4d Molecular Therapeutics In (FDMT)
Ocular Therapeutix (OCUL)
Dyne Therapeutics (DYN)
Merus N V (MRUS)
Kalvista Pharmaceuticals (KALV)
Pharvaris N V (PHVS)
Spyre Therapeutics Com New (SYRE)
Dianthus Therapeutics (DNTH)
Miragen Therapeutics (VRDN)
Cogent Biosciences (COGT)
Applied Therapeutics (APLT)
Erasca (ERAS)
Astria Therapeutics (ATXS)

View all positions for VR Adviser

Top funds holding Perceptive Cap Solutions Cor Cl A

VR Adviser
RA Capital Management
Commodore Capital
683 Capital Management
Shaolin Capital Management
OZ Management
Affinity Asset Advisors
Cowen And Company
Millennium Management
Kepos Capital
Point72 Asset Management
Schonfeld Strategic Advisors
Stempoint Capital
Highbridge Capital Management
Two Sigma Investments

View all funds holding Perceptive Cap Solutions Cor Cl A